J1290 Ecallantide injection
Also known as: Kalbitor, ecallantide
Ecallantide injection, a plasma kallikrein inhibitor for acute attacks of hereditary angioedema.
In Plain Language
Emergency medicine for angioedema attacks
Clinical Context
Used for acute management of hereditary angioedema attacks caused by deficiency or dysfunction of C1 esterase inhibitor.
RVU Information
CPT J1290 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J1290?
CPT J1290 (Ecallantide injection) is a J Codes (Drugs) code. Ecallantide injection, a plasma kallikrein inhibitor for acute attacks of hereditary angioedema.
How is J1290 administered?
CPT J1290 is administered by a healthcare provider, typically via injection or infusion. Used for acute management of hereditary angioedema attacks caused by deficiency or dysfunction of C1 esterase inhibitor. It is used by Allergy/Immunology, Emergency Medicine, Internal Medicine.
When is CPT J1290 used?
Used for acute management of hereditary angioedema attacks caused by deficiency or dysfunction of C1 esterase inhibitor.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.